Article
Modelling oxaliplatin resistance in colorectal cancer reveals a <i>SERPINE1</i> -based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype
2024-12-18
Abstract excerpt
Drug resistance and distant metastases are major contributors to mortality in colorectal cancer (CRC). Here we investigate mechanisms underlying acquired resistance to oxaliplatin, a first-line, standard-of-care CRC treatment. We generated oxaliplatin-resistant CRC tumor cells with clinically relevant dosing regimen, which displayed enhanced metastatic potential. Transcriptomic and phenotypic analyses revealed a c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2c50dd6-e755-510d-9cd4-2aff9d24f63f
- DOI
- 10.1101/2024.12.17.628817
